I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CMSC 2026

We will be contributing to topics related to
-
07:00 PM
Duration 120mins Charlotte, USA
A Decade of Pregnancy Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Over 5000 Pregnancies
Kristne Krysko, Ruth Dobson, Sandra Vukusic, Kerstin Hellwig, Celia Oreja-Guevara, Carlo Pietrasanta, T McElrath, Agne Kazlauskaite, Germano Ferreira, Daniela Alves, Yuliang He, Chien-Ju Lin, Noemi Pasquarelli, Riley Bove
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, NC
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Nicholas, Jacqueline A.; Bar-Or, Amit; Oh, Jiwon; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; von Büdingen, Hans-Christian; Lopez, Jon; Roberts, Louise; Triyatni, Miriam; Qi, Qi; Ratchford, John N.; Napieralski, Julie; Goodyear, Alexandra; Hauser, Stephen L.; Kappos, Ludwig
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 PM
Duration 120mins Charlotte, USA
No Evidence of Disease Activity on Intravenous or Subcutaneous Ocrelizumab in Treatment-Naive Relapsing Multiple Sclerosis in the OPERA (10 Yrs) and OCARINA II (2 Yrs) Trials
Newsome, Scott D., Cerqueira, João; Centonze, Diego; Traboulsee, Anthony; Craveiro, Licinio; Schenble, Hans-Martin; Zecevic, Dusanka; Figueirido, Catarina; Wang, Qing; Giacobino, Caroline; Selmaj, Krzysztof; Cree, Bruce A. C.
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Understanding the Impact and Burden of Menopause on Multiple Sclerosis Through a Targeted Literature Review
Arliene Ravelo, Elmor Pineda, Ibraheem Abioye
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Association Between Socioeconomic Characteristics and Treatment Outcomes With Ocrelizumab in the CHIMES Trial of Black and Hispanic People With Multiple Sclerosis
Angel Chinea, Annette Okai, Anthony Reder, Bhupendra Khatri, Corey McGraw, David Jones, Dilraj Singh Sokhi, Evanthia Bernitsas, Faria Amjad, Gregory Wu, Ibraheem Abioye, Jugena Ndrio, Lawrence Goldstick, Lilyana Amezcua, Mitzi Williams, Nancy Monson
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Effectiveness and Safety of Ocrelizumab in Patients With Pediatric- Vs Young Adult–Onset Multiple Sclerosis: An MSBase Registry Matched Cohort Analysis
Anda Gershon, Corinne Manlius, Erwan Muros, Helmut Butzkueven, Tim Spelman
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Real-World Impact of Discontinuing Ocrelizumab on Healthcare Resource Utilization and Cost Among Older Adult Patients With Multiple Sclerosis in the United States
Achal Patel, Danny Sheinson, Elmor Pineda, Ibraheem Abioye, Zhiyu Xia
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Real-World Study of Ocrelizumab and Other Disease-Modifying Therapy Utilization and Disease Activity from Preconception through Postpartum in Women With MS
Arliene Ravelo, Danny Sheinson, Elmor Pineda, Erwan Muros, Maria Houtchens, Noemi Pasquarelli, Zhiyu Xia
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Treatment Patterns of Ocrelizumab Subcutaneous: An Early Look Into Utilization in a Medicare Population With Multiple Sclerosis
Pineda, Elmor D.; Cellia, Johanna; Kardel, Peter;Sheetz, Caitlin; Abioye, Ibraheem
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 AM
Duration 20mins Room E216ABCD
Efficacy and Safety of Fenebrutinib Vs Teriflunomide In Relapsing Multiple Sclerosis: Results of the Fenhance 1 and 2 Studies
Nicholas, Jacqueline A.;Oh, Jiwon; Bar-Or, Amit; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; von Büdingen, Hans-Chrsitian; Decker-Palmer, Marquita; Loukitcheva, Anastasia; Triyatni, Miriam; Hu, Nan; Choi, Yoonha; Racthford, John N.; Napieralski, Julie; Goodyear, Alexandra; Kappos, Ludwig; Hauser, Stephen L.
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon